Loading your page…
Marketing-authorisation holder
24 medicines in 1 country, as authorisation holder.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
24 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| COSACTHEN0.25 mg / ml · Solution | Tetracosactide | Canada | Marketed | 2020 |
| DERMACHLOR 4 MOUSSE4 % / w/v · Solution | Chlorhexidine | Canada | Marketed | 2020 |
| DERMACHLOR 4 SHAMPOO4 % / w/v · Shampoo | Chlorhexidine | Canada | Marketed | 2017 |
| DERMACHLOR 4 SPRAY CONDITIONER4 % / w/v · Spray | Chlorhexidine | Canada | Marketed | 2017 |
| DERMACHLOR 4 WIPES4 % / w/v · Wipe | Chlorhexidine | Canada | Marketed | 2017 |
| DUOTIC1 mg / ml + 10 mg / ml · Gel | Betamethasone, Terbinafine | Canada | Marketed | 2026 |
| EQUIPALAZONE 1 G1 g / sachet · Powder | Phenylbutazone | Canada | Marketed | 2024 |
| FELIMAZOLE 1.25 MG1.25 mg · Tablet | Thiamazole | Canada | Marketed | 2014 |
| FELIMAZOLE 2.5MG2.5 mg · Tablet | Thiamazole | Canada | Marketed | 2010 |
| FELIMAZOLE 5MG5 mg · Tablet | Thiamazole | Canada | Marketed | 2010 |
| HY-5017 mg / ml · Solution | Hyaluronate | Canada | Marketed | 1998 |
| MIRATAZ2 % / w/w · Ointment | Mirtazapine | Canada | Marketed | 2021 |
| OSPHOS INJECTION60 mg / ml · Solution | Clodronic acid | Canada | Marketed | 2015 |
| OSURNIA1 mg / ml + 10 mg / ml + 10 mg / ml · Gel | Betamethasone, Florfenicol, Terbinafine | Canada | Marketed | 2015 |
| VETORYL 10 MG10 mg · Capsule | Trilostane | Canada | Marketed | 2009 |
| VETORYL 120 MG120 mg · Capsule | Trilostane | Canada | Marketed | 2015 |
| VETORYL 20 MG20 mg · Capsule | Trilostane | Canada | Marketed | 2025 |
| VETORYL 30 MG30 mg · Capsule | Trilostane | Canada | Marketed | 2009 |
| VETORYL 5 MG5 mg · Capsule | Trilostane | Canada | Marketed | 2016 |
| VETORYL 60 MG60 mg · Capsule | Trilostane | Canada | Marketed | 2009 |
| VETROPOLYCIN400 unit / g + 3.5 mg / g + 10000 unit / g · Ointment | Bacitracin, Neomycin, Polymyxin b | Canada | Authorised | |
| VETROPOLYCIN HC400 unit / g + 10 mg / g + 3.5 mg / g + 10000 unit / g · Ointment | Bacitracin, Hydrocortisone, Neomycin, Polymyxin b | Canada | Authorised | |
| ZYCORTAL SUSPENSION25 mg / ml · Suspension | Desoxycortone pivalate | Canada | Marketed | 2016 |
| MALACETIC OTIC2 % / w/w + 2 % / w/w · Solution | Acetic acid, Boric acid | Canada | Cancelled | 2004 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 24 | 23 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
